AARTI PHARMALABS LTDAA

AARTI PHARMALABS LTD

724.00INRR
−10.00−1.36%
At close at 10:26 GMT
INR
No trades
See on Supercharts

AARTIPHARM fundamentals

Key facts

Market capitalization‪69.04 B‬INR
Founded2019
Employees (FY)‪3.18 K‬
CEO
About

Aarti Pharmalabs Ltd. engages in the manufacture and sale of pharmaceutical and nutraceutical products. It offers active pharmaceutical ingredients, pharmaceutical intermediates, new chemical entities, and xathine derivatives. The company was founded on November 22, 2019 and is headquartered in Mumbai, India.

Ownership
‪‪90.63 M‬‬
Free Float shares
‪‪51.34 M‬‬ (56.65%)
Closely held shares
‪‪39.29 M‬‬ (43.35%)
Free Float shares
‪‪51.34 M‬‬ (56.65%)
Closely held shares
‪‪39.29 M‬‬ (43.35%)
Capital structure
Market cap
‪‪69.04 B‬‬
Enterprise value
‪‪69.04 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪69.04 B‬‬
Price to earning ratio (P/E)
27.67x
Price to sales ratio (P/S)
3.23x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
27.67x
Price to sales ratio (P/S)
3.23x
Valuation ratios
‪0.00‬
‪0.80‬
‪1.60‬
‪2.40‬
‪3.20‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪7.00‬
‪14.00‬
‪21.00‬
‪28.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪9.5%‬
‪10.6%‬
‪11.7%‬
‪12.8%‬
‪13.9%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪1.50 B‬‬
‪‪3.00 B‬‬
‪‪4.50 B‬‬
‪‪6.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪1.50 B‬‬
‪‪3.00 B‬‬
‪‪4.50 B‬‬
‪‪6.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪1.50 B‬‬
‪‪3.00 B‬‬
‪‪4.50 B‬‬
‪‪6.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Pharmaceutical
By country
Period: 2023
India
International
Global

Dividends

Dividend yield, history and sustainability

Dividend summary
12.72%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
0.46%
Last payment
2.50
Last ex-date
Feb 14, 2025
Dividend history
‪0.0%‬
‪0.2%‬
‪0.4%‬
‪0.6%‬
‪0.8%‬
2020
2021
2022
2023
‪0.00‬
‪0.80‬
‪1.60‬
‪2.40‬
‪3.20‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪1.00 B‬‬
‪‪2.00 B‬‬
‪‪3.00 B‬‬
‪‪4.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
Assets
Liabilities